The Mary Imogene Bassett Hospital is a teaching hospital in Cooperstown, New York. The hospital opened in June 1922. The hospital has 180 beds. It is associated with Columbia University. It is home to the Bassett Cancer Institute.

There are 180 beds in Mary Imogene Bassett Hospital.

During the past decade, Mary Imogene Bassett Hospital conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 36 clinical trials were completed, i.e. on average, 65.5% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 26 clinical trials were completed. i.e. 123.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mary Imogene Bassett Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 33 trials, followed by "SWOG Cancer Research Network" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "Bassett Healthcare" with 5 trials sponsored and "NRG Oncology" with 5 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Imogene Bassett Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 44 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Mary Imogene Bassett Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Breast Cancer" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IV Lung Cancer AJCC v8" (6 trials) and "Stage IVA Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Mary Imogene Bassett Hospital" in a lesser frequency.

Most popular intervention types in "Mary Imogene Bassett Hospital" are "Drug" (66 trials), "Other" (47 trials), "Biological" (28 trials), "Radiation" (17 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (26 trials), "Quality-of-Life Assessment" (19 trials), "Docetaxel" (10 trials), "Ipilimumab" (8 trials) and "Nivolumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Mary Imogene Bassett Hospital" are 78 trials for "All" genders, 12 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Mary Imogene Bassett Hospital". undefined are not yet recruiting, 19 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Mary Imogene Bassett Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Mary Imogene Bassett Hospital, 0 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

Mary Imogene Bassett Hospital has several departments that took part in Clinical trials: "Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital" - 11 trials